Given the E3 ubiquitin ligase property of both MDM2 and RNF6 in cancer metabolism (37), GLA might exert its antitumor effect on GC cells by blocking MDM2 and RNF6-mediated deregulated ubiquitination processes. The gene discussed is MDM2; the disease is cancer.